
About us
Hi-Sci Solutions Limited leverages the regenerative, immunomodulatory, and anti-inflammatory power of MSC-derived exosomes to develop breakthrough treatments for rare and severe inflammatory diseases with unmet medical needs.
Revolutionising Medicine with Engineered Exosome-Based Therapies
Founded in Cambridge in 2024, we specialise in modifying and loading exosomes with large therapeutic payloads using our proprietary platform. By integrating bioinformatics, AI, and novel engineering techniques, we ensure precise, organ-specific drug delivery, setting new standards in biotechnology.
With a global reach and a commitment to innovation, Hi-Sci Solutions is shaping the future of targeted therapeutics—driving breakthroughs in Drug Delivery Systems, R&D, and Biotech consultancy.
Key Performance Components
Our Mission
"Advancing drug delivery through engineered extracellular vesicles, Hi-Sci Solutions Limited pioneers innovative therapies for challenging diseases. Our mission is to transform healthcare by enhancing precision, efficacy, and patient outcomes."
Our Values
Innovation – We drive cutting-edge advancements in exosome-based drug delivery to transform healthcare.
Integrity & Honesty – Transparency, accountability, and ethical research guide our work.
Safety & Quality – Precision and excellence ensure reliable and effective solutions.
Sustainability – We minimize environmental impact while maintaining efficiency and responsibility.
Empathy & Inclusion – We cultivate a diverse, respectful workplace where every contribution matters.